Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.31 |
| ▸ | ARG2 | P78540 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1668394 | 0.97 | SMN1; SMN2 (0.35) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL11694173 | 0.94 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| Ethane SCHEMBL29158130 | 0.91 | SMN1; SMN2 (0.38) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL11698778 | 0.91 | LMNA (0.36) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL11764622 | 0.91 | LMNA (0.36) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL11690198 | 0.86 | LMNA (0.33) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL11696667 | 0.86 | LMNA (0.33) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL11692885 | 0.85 | SMN1; SMN2 (0.32) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL17669189 | 0.83 | SMN1; SMN2 (0.39) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 | |
| SCHEMBL7701933 | 0.81 | SMN1; SMN2 (0.33) | SMN1; SMN2LMNAALDH1A1HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2561123-B1 | ELECTROCHEMICAL SYNTHESIS OF ARYL-ALKYL SURFACTANT PRECURSOR | FIELD UPGRADING LTD (CA) | 2018-09-12 | — | — | EP | disclosed |
| US-9752081-B2 | Method of producing coupled radical products from biomass | CERAMATEC, INC. (US) | 2017-09-05 | — | — | US | disclosed |
| US-9051656-B2 | Electrochemical synthesis of aryl-alkyl surfacant precursor | CERAMATEC, INC. (US) | 2015-06-09 | — | — | US | disclosed |
| US-20140154766-A1 | Method of Producing Coupled Radical Products from Biomass | CERAMATEC, INC. (US) | 2014-06-05 | — | — | US | disclosed |
| US-8647492-B2 | Method of producing coupled radical products from biomass | CERAMATEC, INC. (US) | 2014-02-11 | — | — | US | disclosed |
| US-20130284607-A1 | METHOD OF PRODUCING COUPLED RADICAL PRODUCTS | CERAMATEC INC (US) | 2013-10-31 | — | — | US | disclosed |
| US-8506789-B2 | Method of producing coupled radical products | CERAMATEC, INC. (US) | 2013-08-13 | — | — | US | disclosed |
| US-20130001095-A1 | METHOD OF PRODUCING COUPLED RADICAL PRODUCTS | CERAMATEC, INC. | 2013-01-03 | — | — | US | disclosed |
| US-20110226633-A1 | ELECTROCHEMICAL SYNTHESIS OF ARYL-ALKYL SURFACANT PRECURSOR | ENLIGHTEN INNOVATIONS INC. (CA) | 2011-09-22 | — | — | US | disclosed |
| US-20110168569-A1 | METHOD OF PRODUCING COUPLED RADICAL PRODUCTS | ENLIGHTEN INNOVATIONS INC. (CA) | 2011-07-14 | — | — | US | disclosed |
| WO-2011011521-A9 | DECARBOXYLATION CELL FOR PRODUCTION OF COUPLED RADICAL PRODUCTS | CERAMATEC, INC. (US) | 2011-07-07 | — | — | WO | disclosed |
| US-20110027848-A1 | METHOD OF PRODUCING COUPLED RADICAL PRODUCTS FROM BIOMASS | ENLIGHTEN INNOVATIONS INC. (CA) | 2011-02-03 | — | — | US | disclosed |
| US-20110024288-A1 | DECARBOXYLATION CELL FOR PRODUCTION OF COUPLED RADICAL PRODUCTS | CERAMATEC, INC. | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110027848-A1 | METHOD OF PRODUCING COUPLED RADICAL PRODUCTS FROM BIOMASS | ACSL3, ACSL4, FASN | SMN1; SMN2 3934/4885LMNA 2149/4885ALDH1A1 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.